Bone Grafts Substitutes Market worth USD 3.5 billion by 2030

The Market Statsville Group (MSG) publishes the new report on the "Bone Grafts Substitutes Market by Product (Allografts, Bone Grafts Substitutes, and Cell-Based Matrices), by Application (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting), by Region – Global Share and Forecast to 2030".

The global bone grafts substitutes market size is projected to grow at a CAGR of 4.3% to reach USD 3.5 billion by 2030 from USD 2.5 billion in 2021. The bone grafts & substitutes market has witnessed remarkable growth due to technological advancements in the medical field. With advancements in technology, the spectrum of grafting material has broadened to xenograft, allograft, and synthetic materials. There has been a shift toward synthetic graft products and expensive demineralized bone matrix, which provides an alternative to autografts. This alternative is developed as autografts, which require increased operative time and two incisions.

Moreover, the rise in number of musculoskeletal treatments, growth in incidences of joint reconstruction, and spinal fusion procedures have led to an increased usage of bone grafts. Bone grafting is the emerging solution to musculoskeletal disorders. Thus, many key companies indulge in expanding and commercializing orthobiologic products (such as bone graft & substitutes) to treat musculoskeletal disorders. Increase in incidences of musculoskeletal conditions has led to rise in usage of bone grafts and their substitutes in the market. Bone graft has become a future cure for complex skeletal defects.

Global Bone Grafts Substitutes Market Segmentation

The overall bone grafts substitutes market has been segmented into the product, application, and region.

By Product Outlook (Sales, USD Billion, 2017-2030)

• Allografts
  • Machined Allografts
  • Demineralized Bone Matrix
• Bone Grafts Substitutes
  • Bone Morphogenic Proteins (BMP)
  • Synthetic Bone Grafts
• Cell-Based Matrices

By Application Outlook (Sales, USD Billion, 2017-2030)

• Spinal Fusion
• Trauma
• Craniomaxillofacial
• Joint Reconstruction
• Dental Bone Grafting

By Region Outlook (Sales, USD Billion, 2017-2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

Spinal fusion, by application type, is estimated to hold the largest market share during the forecast period

Bone grafts & substitutes have a wide range of applications in the field of spinal fusion, trauma, craniomaxillofacial surgery, joint reconstruction, and dental bone grafting. In 2021, spinal fusion had the largest market share of 47.2% in the global bone grafts substitutes market. Spinal fusion is a condition in which a solid bridge is formed between two spine vertebral segments. This bridge stops the movement in that area. Bone grafts and its substitutes provide an ideal environment for the formation of this solid bridge. Wide range of grafts, which are useful in spinal fusion, are present in the market. Iliac crest autograft is considered as a gold standard graft used in spinal fusion.

With the increase in the need of bone grafts for spinal fusion, many companies have started developing and launching novel bone grafts. For instance, in 2019, Medtronic plc received approval from the FDA regarding the use of INFUSE Bone Graft product, which is employed for usage in TLIF spine procedures. In traditional procedures, this product reduces the complications and pain associated with bone harvest.

Don't miss out on business opportunities in Bone Grafts Substitutes Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the largest market share in bone grafts substitutes market 2021

The bone grafts & substitutes market is analyzed across five regions: North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 55.5% in the global bone grafts substitutes market and was anticipated to maintain its dominance throughout the forecast period. The three major countries of North America considered in the report include the Canada, U.S., and Mexico. The U.S. garners the largest market share of the bone grafts & substitutes market due to higher adoption of orthopedic procedures such as spinal fusion, foot & ankle replacement, and other joint reconstruction surgeries.

Upsurge in the geriatric population coupled with bone-related disorders and deformities are major reasons for augmenting the demand for bone grafts & substitute products in the North American region. The rise in the elderly population, favorable reimbursement rates, and technological innovations (such as rh-BMP) drive the growth of the bone graft & substitutes market in this region. The increase in the incidences of orthopedic disorders and the surge in preference for an active lifestyle amongst U.S. citizens is expected to further boost the market growth.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the bone grafts substitutes market. It also consists of the profiles of leading companies such as Arthrex, Inc., Johnson & Johnson (DePuy Synthes), Medtronic Plc., Baxter International Inc., Musculoskeletal Transplant Foundation, NuVasive, Inc., Integra LifeSciences Holdings Corporation, Stryker Corporation, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc.

Browse the complete report: https://www.marketstatsville.com/bone-grafts-substitutes-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com